Dr. Ferguson graduated from the University of Virginia School of Medicine in 1997. He works in Davis, CA and specializes in Urology. Dr. Ferguson is affiliated with Sutter Davis Hospital.
John Whitaker - Woodinville WA, US Inigo Tejada - Madrid, ES Kenneth Ferguson - Bothell WA, US
International Classification:
A61K031/4985
US Classification:
514/250000
Abstract:
The present invention relates to phosphodiesterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic quanosine 3′,5′-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 10 mg unit dosage are useful for the treatment of sexual dysfunction by daily administration of the PDE5 inhibitor. The articles of manufacture described herein are characterized by PDE5 inhibition, and accordingly, provide a benefit in therapeutic areas where inhibition of PDE5 is desired, especially erectile dysfunction, with minimization or elimination of adverse side effects resulting from inhibition of other phosphodiesterase enzymes and with an improvement of -vascular conditioning.
Daily Treatment For Erectile Dysfunction Using A Pde5 Inhibitor
John Whitaker - Woodinville WA, US Inigo Tejada - Madrid, ES Kenneth Ferguson - Bothell WA, US
Assignee:
Lilly ICOS LLC
International Classification:
A61K031/498 A61K031/496 A61K031/519
US Classification:
514/249000, 514/252160, 514/262100, 514/250000
Abstract:
The present invention relates to phosphodiesterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic guanosine 3′,5′-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 10 mg unit dosage are useful for the treatment of sexual dysfunction by daily administration of the PDE5 inhibitor. The articles of manufacture described herein are characterized by PDE5 inhibition, and accordingly, provide a benefit in therapeutic areas where inhibition of PDE5 is desired, especially erectile dysfunction, with minimization or elimination of adverse side effects resulting from inhibition of other phosphodiesterase enzymes and with an improvement of vascular conditioning.
License Records
Kenneth L Ferguson
License #:
6149 - Active
Category:
Tow Truck Operator (Incident Management)
Expiration Date:
Oct 23, 2017
Kenneth L Ferguson
License #:
1951 - Active
Category:
VSF Employee
Expiration Date:
Jun 27, 2017
Youtube
Kenneth Ferguson's Birthday
aboard the Celebrity Infinity
Category:
People & Blogs
Uploaded:
10 Nov, 2010
Duration:
31s
The Art of the Warrior I - Paintings by Kenne...
The Art of the Warrior I. Original Watercolor Paintings by Kenneth Fer...
Medora Elementary School Valley Station KY 1978-1980, Eisenhower Elementary School Louisville KY 1981-1985, Stuart High School Valley Station KY 1984-1986, Meyzeek Middle School Louisville KY 1986-1987